Rebalancing immune homeostasis in combating disease: the impact of medicine food homology plants and gut microbiome DOI

Lu Xia,

Chuangen Li, Jia Zhao

et al.

Phytomedicine, Journal Year: 2024, Volume and Issue: 136, P. 156150 - 156150

Published: Oct. 24, 2024

Language: Английский

Akkermansia muciniphila Protects Against Trinitrobenzene Sulfonic Acid Induced Colitis by Inhibiting IL6/STAT3 Pathway DOI
Mingshan Jiang,

Yongbin Jia,

Chunxiang Ma

et al.

Inflammatory Bowel Diseases, Journal Year: 2025, Volume and Issue: unknown

Published: April 10, 2025

Abstract Background Inflammatory bowel disease is a long-standing inflammatory disorder that influences the intestinal tract. The intent of this research to explore whether relative abundance Akkermansia muciniphila related IL6/STAT3 pathway and fundamental molecular mechanisms A. on trinitrobenzene sulfonic acid (TNBS)-induced enteritis mouse model, including expression cytokines proteins in signaling pathway. Methods association between was investigated by using mucosal biopsies fecal samples. TNBS-induced colitis models were performed elucidate underlying mechanisms. alteration microbiota organized 16s rRNA sequencing. Results In Crohn’s patients, level STAT3 IL-6 presented negative relationship with muciniphila. IL-6, p-STAT3, downregulated A.m+TNBS group, indicating may inhibit vivo. To investigate potential defensive role supplementation vivo enteritis, 16S sequencing analyze changes composition. results revealed marked increase microbial diversity within muciniphila-treated suggesting beneficial modulation gut microbiome associated supplementation. Conclusions Our findings declared alleviates gastrointestinal inflammation through IL-6/STAT3 This protective effect mediated downregulation STAT3, highlighting mechanism which modulates responses. work disclosed demonstrates influence against vivo, proposing it qualified as unique therapeutic focusing modulating or p-STAT3 treatment colitis.

Language: Английский

Citations

0

The influence of the gut microbiota on B cells in autoimmune diseases DOI Creative Commons

Lun He,

Xin Li, Shan Jiang

et al.

Molecular Medicine, Journal Year: 2025, Volume and Issue: 31(1)

Published: April 22, 2025

Abstract Mounting evidence shows that gut microbiota communities and the human immune system coexist influence each other, there are a number of reports correlation between specific changes in occurrence autoimmune diseases. B lymphocytes play central role regulation both Here, we summarize microbiota-B cell pathways on diseases how cells regulate microorganisms, which provides mechanistic insights with relevance for identification potential therapeutic targets related fields.

Language: Английский

Citations

0

Thlaspi arvense suppresses gut microbiota related TNF inflammatory pathway to alleviates ulcerative colitis DOI Creative Commons
Wenkai Wang, Yiyang Zhao, Ziwei Wang

et al.

Frontiers in Immunology, Journal Year: 2025, Volume and Issue: 16

Published: April 22, 2025

Thlaspi arvense (TA), commonly known as "Ximi" or "Subaijiang," is a traditional Chinese medicinal herb used to prevent and treat ulcerative colitis (UC). However, the precise mechanisms underlying its therapeutic effects remain unclear, necessitating further investigation identify potential pharmaceutical applications for UC management. This study aims elucidate efficacy of TA active constituents in treatment. first evaluated varying doses on 3% dextran sulfate sodium (DSS)-induced UC. Gut microbiota alterations mice were analyzed via 16S rRNA sequencing, with correlation analyses reveal relationship between gut cytokines. Then, network pharmacology was utilized identified targets Protein-protein interaction (PPI) networks, Gene Ontology (GO), Kyoto Encyclopedia Genes Genomes (KEGG) enrichment employed explore TA's mechanisms. Molecular docking dynamics simulations validated interactions compounds UC-related targets. Finally, TNF pathway modulation by component, isovitexin, verified vitro vivo. alleviated DSS-induced weight loss dose-dependent manner, reduced disease activity indices, preserved intestinal mucosal barrier integrity. Subsequently, fluorescence situ hybridization (FISH) revealed suppressed microbial translocation tissues. To characterize inflammatory responses, ELISA demonstrated that modulated levels key cytokines (TNF-α, IL-1β, IL-6, IL-10) oxidative stress markers (SOD, MDA), indicating systemic anti-inflammatory effects. Building these findings, sequencing showed regulated alpha/beta diversity inhibited infectious disease-related pathways. Notably, heatmaps highlighted strong association TNF-α Escherichia-Shigella abundance, high-dose significantly reducing this pathogenic bacterial genus. systematically molecular mechanisms, 220 Consistent experimental data, PPI KEGG implicated TNF-α, AKT targets, primarily through signaling modulation. validate predictions, confirmed stable while specifically emphasized isovitexin's high affinity TNF-α. experiments vivo inhibition TNF-α-mediated NF-κB activation, studies isovitexin directly mitigated TNF-α-induced epithelial damage. Furthermore, potent activation tissues, constituent effectively cell damage, collectively highlighting their complementary Collectively, (TA) ameliorates synergistic involving modulation, suppression, preservation. By remodeling communities reduce colonization translocation. concurrently inhibits TNF-α/NF-κB-driven inflammation, regulation. attenuates demonstrating multi-scale efficacy. These findings establish multi-target spanning host-microbe intracellular signaling, providing rationale standardizing TA-based formulations advancing precision agent bowel diseases.

Language: Английский

Citations

0

The gastrointestinal mycobiome in inflammation and cancer: unraveling fungal dysbiosis, pathogenesis, and therapeutic potential DOI

Neelakanta Sarvashiva Kiran,

Ankita Chatterjee,

Chandrashekar Yashaswini

et al.

Medical Oncology, Journal Year: 2025, Volume and Issue: 42(6)

Published: May 5, 2025

Language: Английский

Citations

0

Combination of probiotics enhancing butyrogenesis in colonic microbiota model of patients with ulcerative colitis DOI Creative Commons

Kentaro Inokuma,

Daisuke Sasaki, Tomoya Shintani

et al.

Applied Microbiology and Biotechnology, Journal Year: 2025, Volume and Issue: 109(1)

Published: May 10, 2025

Administering beneficial bacteria as probiotics to restore the intestinal microbiota and its metabolic functions, such butyrogenesis, is a promising treatment strategy in ulcerative colitis (UC). This study aimed investigate effect of combination probiotics, consisting lactic acid bacterium Weizmannia coagulans SANK70258 lactate-utilizing butyrate-producing Anaerostipes caccae or Clostridium butyricum, on colonic environment using an vitro culture model with fecal inoculums from seven patients UC. Co-inoculated W. A. neither inhibited each other's growth nor significantly affected relative abundance other bacterial species; however, was when co-inoculated C. butyricum. The pro-inflammatory (Escherichia sp. unclassified Enterobacteriaceae) Bifidobacterium spp. decreased coagulans-C. butyricum cultures. Inoculation any alone did not increase butyrate production, whereas co-inoculation increased levels. Overall, results suggested that have synergistic effects through cross-feeding can effectively butyrogenesis KEY POINTS: • Effects were evaluated UC colon. producers effects. Co-inoculation enhanced butyrogenesis.

Language: Английский

Citations

0

Links between short-chain fatty acids and osteoarthritis from pathology to clinic via gut-joint axis DOI Creative Commons
Juanjuan Han, Xin Meng, Hui Kong

et al.

Stem Cell Research & Therapy, Journal Year: 2025, Volume and Issue: 16(1)

Published: May 19, 2025

Short-chain fatty acids (SCFAs), the primary metabolites produced by microbial fermentation of dietary fibers in gut, have a key role protecting gut health. Increasing evidence indicates SCFAs can exert effects on distant tissues and organs beyond via blood circulation. Osteoarthritis (OA) is chronic inflammatory joint disease that severely diminishes physical function quality life. However, effective clinical treatments for OA remain elusive. Recent studies shown beneficial damaged joints OA. mitigate progression preserving intestinal barrier maintaining integrity cartilage subchondral bone, suggesting they substantial potential to be adjunctive treatment strategy This review described human body their cellular signaling mechanism, summarized multiple (especially butyrate, propionate, acetate) prevention regulating gut-joint axis, providing novel insights into promising applications.

Language: Английский

Citations

0

Neuroimmune interactions: The bridge between inflammatory bowel disease and the gut microbiota DOI Creative Commons
Jinxia Zhai,

Yingjie Li,

Jiameng Liu

et al.

Clinical and Translational Medicine, Journal Year: 2025, Volume and Issue: 15(5)

Published: May 1, 2025

Abstract Background The multidimensional regulatory mechanism of the gut–brain–immune axis in context inflammatory bowel disease (IBD) has garnered significant attention, particularly regarding how intestinal microbiota finely regulates immune responses through cells and sensory neurons. Main Body Metabolites produced by influence phenotype switching via complex signalling pathways, thereby modulating their anti‐inflammatory pro‐inflammatory functions during inflammation. Furthermore, neurons exhibit heightened sensitivity to microbial‐derived signals, which is essential for preserving balance controlling pathological inflammation integrating peripheral environmental signals with local responses. dynamic equilibrium between neuroimmunoregulation mediated collectively sustains homeostasis within intestine. However, this coordination markedly disrupted under conditions associated IBD. Conclusion An in‐depth exploration interactions among cells, gut may yield insights into mechanisms underlying IBD guide creation new treatment approaches. Key points gut‐brain‐immune axis, neuroimmune Microbiota‐derived metabolites affecting Neurons secrete mediators, enabling bidirectional communication homeostasis. Disruptions contribute IBD, offering therapeutic targets.

Language: Английский

Citations

0

Protective effect of 1,3-dioleoyl-2-palmitoylglycerol against DSS-induced colitis via modulating gut microbiota and maintaining intestinal epithelial barrier integrity DOI

Wusun Li,

Xiaoyan Tang, Hui Liu

et al.

Food & Function, Journal Year: 2024, Volume and Issue: 15(17), P. 8700 - 8711

Published: Jan. 1, 2024

A schematic diagram illustrates how OPO protects against DSS-induced colitis by modulating gut microbiota, enhancing intestinal epithelial barrier integrity, and subsequently downregulating the TLR4-MyD88-NF-κB signaling pathway.

Language: Английский

Citations

3

Gut microbiota and renal fibrosis DOI

Yinghao Tong,

Shangze Guo,

Ting Li

et al.

Life Sciences, Journal Year: 2024, Volume and Issue: unknown, P. 123072 - 123072

Published: Sept. 1, 2024

Language: Английский

Citations

3

Effects of Pine Pollen Polysaccharides and Sulfated Polysaccharides on Ulcerative Colitis in Mice by Regulating Th17/Treg DOI Creative Commons
Zhanjiang Wang, Zhenxiang Li,

Hanyue Wang

et al.

Foods, Journal Year: 2024, Volume and Issue: 13(19), P. 3183 - 3183

Published: Oct. 7, 2024

This study was to investigate the effects of polysaccharides (PPM60-III) and sulfated (SPPM60-III) pine pollen on Th17/Treg balance, inflammatory cytokines, intestinal microbiota, metabolite distribution in 3% DSS drinking water-induced UC mice. First all, physiological results showed that PPM60-III SPPM60-III could alleviate UC, which shown by reduction liver Treg cells, rebalance Th17/Treg, modulation cytokines. In addition, 16S rRNA decrease

Language: Английский

Citations

3